Discovery of a G Protein-Biased Radioligand for the Histamine H2 Receptor with Reversible Binding Properties
- PMID: 33108724
- DOI: 10.1021/acs.jmedchem.0c01494
Discovery of a G Protein-Biased Radioligand for the Histamine H2 Receptor with Reversible Binding Properties
Abstract
Currently employed histamine H2 receptor (H2R) radioligands possess several drawbacks, for example, high non-specificity, insurmountable binding, or short half-life. We report the synthesis and the chemical and pharmacological characterization of the highly stable carbamoylguanidine-type radioligand [3H]UR-KAT479 ([3H]23), a subtype selective histamine H2 receptor G protein-biased agonist. [3H]23 was characterized by saturation, kinetic, and competition binding assays at the human, guinea pig, and mouse H2 receptors (co-)expressed in HEK293(T) cells. [3H]23 reversibly bound to the respective H2Rs with moderate to high affinity (human/guinea pig/mouse Kd: 24/28/94 nM). In order to investigate the applicability of carbamoylguanidine-type ligands in animal studies elucidating the role of the H2R in the brain, we performed a preliminary partitioning experiment in the whole human/mouse blood, which indicated a low binding of [3H]23 to red blood cells. These properties turn [3H]23 into a powerful tool for the determination of binding affinities and demonstrate the promising pharmacokinetic profile of carbamoylguanidine-type ligands.
Similar articles
-
[(3) H]UR-DE257: development of a tritium-labeled squaramide-type selective histamine H2 receptor antagonist.ChemMedChem. 2015 Jan;10(1):83-93. doi: 10.1002/cmdc.201402344. Epub 2014 Oct 15. ChemMedChem. 2015. PMID: 25320025
-
Pharmacological characterization of a new series of carbamoylguanidines reveals potent agonism at the H2R and D3R.Eur J Med Chem. 2021 Mar 15;214:113190. doi: 10.1016/j.ejmech.2021.113190. Epub 2021 Jan 19. Eur J Med Chem. 2021. PMID: 33548637
-
Dimeric carbamoylguanidine-type histamine H2 receptor ligands: A new class of potent and selective agonists.Bioorg Med Chem. 2015 Jul 15;23(14):3957-69. doi: 10.1016/j.bmc.2015.01.012. Epub 2015 Jan 14. Bioorg Med Chem. 2015. PMID: 25639885
-
Histamine H2 receptor radioligands: triumphs and challenges.Future Med Chem. 2021 Jun;13(12):1073-1081. doi: 10.4155/fmc-2021-0058. Epub 2021 Apr 28. Future Med Chem. 2021. PMID: 33906421 Review.
-
Structure-activity relationships of histamine H2 receptor ligands.Mini Rev Med Chem. 2004 Nov;4(9):941-54. doi: 10.2174/1389557043403242. Mini Rev Med Chem. 2004. PMID: 15544555 Review.
Cited by
-
Specific Engineered G Protein Coupling to Histamine Receptors Revealed from Cellular Assay Experiments and Accelerated Molecular Dynamics Simulations.Int J Mol Sci. 2021 Sep 17;22(18):10047. doi: 10.3390/ijms221810047. Int J Mol Sci. 2021. PMID: 34576210 Free PMC article.
-
Clonidine stimulates force of contraction via histamine H2 receptors in the human atrium.Naunyn Schmiedebergs Arch Pharmacol. 2024 Jan;397(1):617-626. doi: 10.1007/s00210-023-02635-x. Epub 2023 Jul 25. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37490122 Free PMC article.
-
Discovery of a Tritiated Radioligand with High Affinity and Selectivity for the Histamine H3 Receptor.ACS Med Chem Lett. 2023 Oct 17;14(11):1589-1595. doi: 10.1021/acsmedchemlett.3c00413. eCollection 2023 Nov 9. ACS Med Chem Lett. 2023. PMID: 37974943 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources